期刊文献+

氯氮平合并安度利可治疗难治性精神分裂症对照研究 被引量:1

下载PDF
导出
摘要 目的 :了解氯氮平合并安度利可治疗难治性精神分裂症的疗效和不良反应。 方法 :6 8例难治性精神分裂症随机分为合用组和单用组 ,治疗前及治疗 1、2、4、6个月末进行简明精神病评定量表(BPRS)和副反应量表 (TESS)评定疗效及不良反应。 结果 :总疗效合用组明显高于单用组。 结论 :氯氯氮平合并安度利可治疗难治性精神分裂症疗效较好 。
出处 《临床精神医学杂志》 2004年第6期363-363,共1页 Journal of Clinical Psychiatry
  • 相关文献

参考文献3

二级参考文献16

  • 11.Kane J.Treatment-resistant schizophrenic patient.J Clin Psychiatry,1996,57(suppl 9):35 被引量:1
  • 24.Kane J,Honigfild G,Singer J,et al.Clozapine for the treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine.Arch Gen Psychiatry,1988,45:789 被引量:1
  • 35.Kane J.Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.Br J Psychiatry,1992,160(suppl 17):41 被引量:1
  • 47.Marder SR,Meibach RC.Risperidone in the treatment of schizophrenia.Am J Psychiatry,1994,151:825 被引量:1
  • 58.Bondolfi G,Dufour H,Patris M,et al.Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study.Am J Psychiatry,1998,155:499 被引量:1
  • 69.Lieberman JA.Atypical antipsychotic drugs as a first line treatment of schizophrenia.J Clin Psychiatry,1996,57(suppl 11):68 被引量:1
  • 710.Marder SR.Management of treatment-resistant patient with schizophrenia.J Clin Psychiatry,1996,57(suppl 11):26 被引量:1
  • 8Morrison Dp.Management of treatment refractory schizophrenia.Br J Psychiatry,1996,169(suppl 31):15 被引量:1
  • 9Kine J,Hongigfeld G,Singer J,et al.Clozapine for the treatment-resistant schizophrenic:a double-blind comparison with chlorpromazine.Arch Gen Psychiatry,1988,45:789 被引量:1
  • 10Perry PJ,Miller DD,Arnclt SV.Clozapine and nor clozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.Am J Psychiatry,1991,148:231 被引量:1

共引文献145

同被引文献8

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 2Chong MY, Tan CH, Fujii S, et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change [ J]. Psychiatry Clin Neurosciences, 2004,58 : 61-67. 被引量:1
  • 3Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review[ J]. J Clin Psychiatry, 2003,64 : 30-34. 被引量:1
  • 4Sebastian CS, Glazer W, Peter F. Buckley Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia[ J ]. Current Med Chemistry, 2004, 11,329-342. 被引量:1
  • 5Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia [J]. Am J Psychiatry, 2002, 159: 567-572. 被引量:1
  • 6Semyak M J, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia [J]. Am J Psychiatry,2002,159:561-566. 被引量:1
  • 7Rothbard AB, Kuno E, Foley K. Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia [ J ]. Schizophr Bull, 2003,29 : 531-540. 被引量:1
  • 8张明廉,袁国桢,姚建军,周德祥.精神病院住院患者抗精神病药物使用情况变迁分析[J].中国神经精神疾病杂志,2003,29(2):97-97. 被引量:23

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部